Abstract

Mastitis affects both dairy and meat/wool sheep industries with losses due to reductions in milk quality and quantity, increased treatment costs and restricted lamb growth. Effective vaccines would be important tools for mastitis control. However, the development of vaccines against mastitis has proved challenging due to the failure to target protective immunity to the mammary gland. In order to target responses to the mammary gland, this study tested whether local administration directly into the gland through the teat canal or in the udder skin confers protection against an intramammary infection. In this study, we tested a vaccine that confers protection against respiratory disease caused by Mannheimia haemolytica to determine if it also protects against intramammary infection by the same organism. No evidence of protection was observed in animals that received a subcutaneous immunisation in the udder skin, however, intramammary immunisation provided almost complete protection against an experimental challenge administered 7 days post immunisation but not if the challenge was delivered 14 days post immunisation. To investigate further the nature of this variation in response, the somatic cell count and concentration of cytokines Interleukin-1β, Interleukin-10 and Interleukin-17A was determined in milk over the course of each study. Intramammary immunisation induced an inflammatory response within the mammary gland, characterised by increases in SCC and in the production of cytokines IL-1β, IL-10, and IL-17A. This response was similar to that observed in un-vaccinated control animals post challenge. The SCC and cytokine levels had returned to levels comparable with un-vaccinated controls prior to challenge at both 7 and 14 days post immunisation. The transient nature of the protective effect is consistent with the priming of an innate antibacterial response within the mammary gland which provides protection against challenge at 7 days but is diminished by 14 days post-vaccination. Further studies are planned to determine the nature of the innate immune mechanisms associated with the protective effect described here to determine whether it may be exploited to improve ruminant udder health.

Highlights

  • Mastitis or inflammation of the mammary gland is most often caused by an intramammary infection (IMI) by a range of Grampositive and negative species of bacteria

  • The most common bacterial species associated with ovine mastitis are Staphylococcus aureus, Streptococcus uberis, Mannheimia haemolytica, and several species of coagulase negative staphylococci (CNS) [4, 5]

  • No evidence of early protection against challenge was observed in animals that received the subcutaneous vaccination, with 16 of the 20 mammary halves infected at 24 h post challenge (PC) (Figure 2A)

Read more

Summary

Introduction

Mastitis or inflammation of the mammary gland is most often caused by an intramammary infection (IMI) by a range of Grampositive and negative species of bacteria. IMIs impact both dairy and meat/fibre sheep production systems worldwide through reduction in the quantity and quality of milk production. Mastitis appears in a number of forms including a long lasting subclinical inflammatory form or a more acute clinical form which is a painful inflammatory condition with clear animal welfare implications and which may lead to the death or premature culling of animals from affected flocks [2]. The most common bacterial species associated with ovine mastitis are Staphylococcus aureus, Streptococcus uberis, Mannheimia haemolytica, and several species of coagulase negative staphylococci (CNS) [4, 5]. In meat production systems M. haemolytica is one of the most frequently identified causes of mastitis [5,6,7,8]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.